2001
DOI: 10.1016/s0361-9230(01)00450-6
|View full text |Cite
|
Sign up to set email alerts
|

Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
30
0
2

Year Published

2002
2002
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(35 citation statements)
references
References 21 publications
3
30
0
2
Order By: Relevance
“…8-iso-PGF2 ␣ is a useful marker of lipid peroxidation for the assessment of the OS condition [39,40] . A significant increase in 8-iso-PGF2 ␣ has been observed in the CSF [41] , plasma [42] , and urine [43,44] of AD patients, which is therefore similar to our present results. These data suggested that OS was associated with the pathogenesis of AD.…”
Section: Discussionsupporting
confidence: 92%
“…8-iso-PGF2 ␣ is a useful marker of lipid peroxidation for the assessment of the OS condition [39,40] . A significant increase in 8-iso-PGF2 ␣ has been observed in the CSF [41] , plasma [42] , and urine [43,44] of AD patients, which is therefore similar to our present results. These data suggested that OS was associated with the pathogenesis of AD.…”
Section: Discussionsupporting
confidence: 92%
“…They are elevated in conditions associated with oxidative stress, including smoking, diabetes, heart disease, and AD. The isoprostane isoforms, iPF2␣-III and iPF2␣-VI, are elevated in AD patients (Montine et al, 1998;Pratico et al, 1998;Tuppo et al, 2001) as well as in patients with mild cognitive impairment, a prodromal phase of AD (Pratico et al, 2002). In addition, the Tg2576 mouse model of AD-like A␤ pathology (Hsiao et al, 1996), in which APP 695 with the Swedish familial mutation (APP sw ) is overexpressed, also shows elevated iPF2␣-VI levels before the onset of amyloid plaque formation (Pratico et al, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…41 A search for a peripheral biomarker of oxidative damage in AD patients has been the focus of research by several groups in the last years. [42][43][44][45][46] A good biomarker could increase the diagnostic accuracy, help to identify mild cognitive impairment in subjects with risk to progress to AD and provide a useful monitor of pharmacological response. 44 The findings that both AD and mild cognitive impairment in patients showed an increase in the amount of oxidized DNA bases in peripheral cells when compared to controls are an indication that oxidative stress could be an earlier event in the pathogenesis of AD.…”
Section: Discussionmentioning
confidence: 99%